ClotCare: Blood Clots, Stroke, Heart Attack
Saturday, October 12, 2024
Home   |   DVT/PE   |   Blood Clots   |   Coumadin/Warfarin   |   New Patients   |   Self Testing   |   Email List   |   Donate

Pick a Topic:

Find info on a:

We subscribe to the HONcode principles of the HON Foundation. Click to verify.
ClotCare complies with the HONcode standard for trustworthy health
information:
verify here.

ClotCare is a member of the Coalition to Prevent Deep Vein Thrombosis (DVT Coalition)  ClotCare is a member organization of the Coalition to Prevent Deep Vein Thrombosis. Click here to learn more about the Coalition to Prevent Deep Vein Thrombosis and DVT Awareness Month, which is held each March.

Postings on Anti-Xa

Postings for Patients & Caregivers Date Posted
A Contrarian’s View on the 2018 Chest Guideline for Antithrombotic Therapy in Atrial Fibrillation November 2018
Rivaroxaban or Warfarin in Stable Coronary Artery Disease – Should the COMPASS Study Lead Us Back to the Future? September 2017
Deep Vein Thrombosis and Pulmonary Embolism Brochure from Clot Connect January 2013
Alliance for Aging Research Releases Survey of AFib Patients 65+ that Finds Active Participation in Treatment Decisions November 2012
DVT & PE: What Patients Need to Know - A Video Series on Blood Clots from July 2012
FDA Approves rivaroxaban (Xarelto) for DVT/PE prevention with knee and hi December 2011

Postings for Healthcare Providers Date Posted
A Contrarian’s View on the 2018 Chest Guideline for Antithrombotic Therapy in Atrial Fibrillation November 2018
Rivaroxaban or Warfarin in Stable Coronary Artery Disease – Should the COMPASS Study Lead Us Back to the Future? September 2017
Silver Book: Atrial Fibrillation Fact Sheet August 2013
Rivaroxaban (and similar agents) for extended prophylaxis of venous thrombosis in high risk medical patients – equal efficacy but increased bleeding March 2013
Deep Vein Thrombosis and Pulmonary Embolism Brochure from Clot Connect January 2013
Aspirin, Apixaban, or Warfarin for Extended Treatment of Venous Thrombosis? January 2013
Alliance for Aging Research Releases Survey of AFib Patients 65+ that Finds Active Participation in Treatment Decisions November 2012
Novel Anticoagulants Should not Replace Warfarin; Head-to-Head Trial Needed September 2012
Rivaroxaban approved for stroke prevention in non-valvular atrial fibrill February 2012
New Chest Guidelines Available Now February 2012
Apixaban in VTE prevention in knee surgery compared to enoxaparin – Confl December 2011
FDA Approves rivaroxaban (Xarelto) for DVT/PE prevention with knee and hi December 2011
Rivaroxaban vs a Vitamin K antagonist (EINSTEIN-DVT trial) July 2011

Ask a question about blood clots or anticoagulant medications Have questions? Ask ClotCare. Send questions by email to webmaster@clotcare.org.

ClotCare is a 501(c)(3) non-profit organization generously supported by your tax-deductible donations and grants from our industry supporters.

Blood Clot Activities Calendar

New Postings:

Click here to view full list of new postings
ClotCare Home | New Postings | Patient Postings | Clinician Postings | Join Our Email List | Useful Web Links
CE Opportunities | Training Programs | DVT & PE Stories | Editorial Board | Financial Support
About ClotCare | DVT Coalition | Donate to ClotCare | Contact Us
Key topics discussed on ClotCare include: Blood Clots | Deep Vein Thrombosis (DVT) | Pulmonary Embolism (PE) | Atrial Fibrillation (A. Fib or AF) | Heart Attack | Stroke | Transient Ischemic Attack (TIA) | Mini Stroke | Bleeding Complications | Vascular Surgery | Surgical Blood Clot Removal | Warfarin | Coumadin | Lovenox | Low Molecular Weight Heparin (LMWH) | Heparin | Anticoagulants | Plavix | Aspirin | Antiplatelets | Blood Thinners
Copyright 2000-2018 by ClotCare. All rights reserved.
Terms, Conditions, & Privacy | Image Copyright Information
19260 Stone Oak Parkway, Suite 101 | San Antonio, TX 78258 | 210-860-0487
Send comments to webmaster@clotcare.org.
Saturday, October 12, 2024